Zynteglo 73554-3111-01
Generic: Betibeglogene Autotemcel
- Manufacturer
- Genetix Biotherapeutics Inc.
- Dosage Form
- Suspension
- Route
- Intravenous
- Product Type
- Cellular Therapy
- Marketing Start
- August 17, 2022
- Listing Expires
- December 31, 2027
- Application
- BLA125717
Active Ingredients
| Ingredient | Strength |
|---|---|
| Betibeglogene Autotemcel | 20000000 1/1 |
Selected Package
73554-3111-01Selected1 SUSPENSION in 1 BAG (73554-3111-1)